Serpenta

We are a deeptech company developing medical robots for endoluminal surgery in the lower GI. We specialise in soft and continuum robots with fluidic actuation, which we believe will be the future of surgery. Our core product, under development, is a bi-manual snake-robot for colorectal cancer treatment. We aim to enable endoluminal procedures such as endoscopic submucosal dissection (ESD) to be performed at a large scale with high precision and low risk thanks to our advanced technology. Our robot is based on a design created and patented by our CTO during his doctorate at Imperial College London. This is now being expanded and further developed to create a full robotic device that will enable high precision and dextrous surgery anywhere in the colon with highly flexible transmission lines. Our vision is to revolutionise lower GI surgery leading to lower risk, lower cost, and better patient outcomes. We are a start-up with private investment in a growth phase.